Dr. D Pharma

D-DOX 200MG

Cefpodoxime Proxetil 200 mg tablets are third-generation cephalosporin antibiotics used to treat respiratory tract, urinary tract, skin, and ear infections. They work by inhibiting bacterial cell wall synthesis, offering broad-spectrum coverage against Gram-positive and Gram-negative bacteria.

Ofloxacin 200 mg + Ornidazole 500 mg (blister) is a broad-spectrum antimicrobial combination used to treat mixed bacterial and protozoal infections, particularly in the gastrointestinal and genitourinary tracts, offering dual action against aerobic, anaerobic bacteria, and protozoa.

Doxycycline HCl 100 mg with lactic acid bacillus (blister) is a broad-spectrum antibiotic with probiotics, used to treat respiratory, urinary, and skin infections while maintaining gut flora balance, reducing antibiotic-associated diarrhea, and improving gastrointestinal tolerance during therapy.

DCEFI-CV

Cefixime 200 mg + Clavulanic acid 125 mg is a potent antibiotic combination used to treat resistant bacterial infections of the respiratory tract, urinary tract, and ENT regions. Clavulanic acid enhances cefixime’s effectiveness by inhibiting beta-lactamase–producing bacteria.

Amoxicillin 500 mg is a broad‑spectrum penicillin antibiotic used to treat respiratory, urinary, ear, skin, and gastrointestinal infections. It works by inhibiting bacterial cell wall synthesis, effectively targeting a wide range of Gram‑positive and Gram‑negative organisms for reliable infection management.

Additional Information:

• Delivery Time: 4-5 Days

Azithromycin Trihydrate 250 mg is a macrolide antibiotic used to treat respiratory, skin, and soft tissue infections, as well as certain sexually transmitted diseases. It works by inhibiting bacterial protein synthesis, providing broad‑spectrum coverage against various Gram‑positive and Gram‑negative pathogens.

DAZI-500

Azithromycin Trihydrate 500 mg is a macrolide antibiotic used to treat respiratory tract, skin, soft tissue, and certain sexually transmitted infections. It works by inhibiting bacterial protein synthesis, offering broad‑spectrum coverage against Gram‑positive, Gram‑negative, and atypical pathogens for effective treatment.

Additional Information:

• Delivery Time: 6 DAYS

DCEFI-200

Cefixime Dispersible Tablets are a third-generation cephalosporin antibiotic used to treat a variety of bacterial infections. They work by inhibiting bacterial cell wall synthesis, effectively stopping the growth of infection-causing bacteria. Commonly prescribed for respiratory tract, urinary tract, ear, and throat infections, they offer convenient oral administration with good patient compliance.

Ofloxacin 200 mg (Alu-Alu) is a broad-spectrum fluoroquinolone antibiotic used to treat respiratory, urinary, gastrointestinal, and skin infections. It works by inhibiting bacterial DNA replication, offering effective action against Gram-positive and Gram-negative organisms.

DCEFI-O TAB

Cefixime 200 mg + Ofloxacin 200 mg is a broad‑spectrum antibiotic combination used to treat respiratory, urinary, gastrointestinal, and skin infections. Cefixime inhibits bacterial cell wall synthesis, while Ofloxacin disrupts DNA replication, providing dual action against Gram‑positive and Gram‑negative bacteria for enhanced efficacy.

Cefpodoxime 200 mg + Potassium Clavulanate 125 mg (325 mg tablet) is a broad‑spectrum antibiotic combination for respiratory, urinary, skin, and ENT infections. Cefpodoxime inhibits bacterial cell wall synthesis, while Clavulanate blocks beta‑lactamase enzymes, enhancing effectiveness against resistant bacterial strains for improved treatment outcomes.

DEECIP-500 TAB

Ciprofloxacin 500 mg tablets are broad‑spectrum fluoroquinolone antibiotics used to treat respiratory, urinary, gastrointestinal, and skin infections. They work by inhibiting bacterial DNA gyrase and topoisomerase IV, effectively preventing bacterial replication and ensuring rapid action against a wide range of Gram‑negative and Gram‑positive pathogens.

Amoxicillin 250 mg + Potassium Clavulanate 125 mg is a broad‑spectrum antibiotic combination for respiratory, urinary, skin, and ENT infections. Amoxicillin inhibits bacterial cell wall synthesis, while Clavulanate blocks beta‑lactamase enzymes, enhancing effectiveness against resistant bacteria for improved therapeutic outcomes.

Amoxicillin 400 mg + Potassium Clavulanate 57 mg is a broad‑spectrum antibiotic combination used for respiratory, urinary, skin, and ENT infections. Amoxicillin inhibits bacterial cell wall synthesis, while Clavulanate prevents beta‑lactamase–mediated resistance, enhancing efficacy against beta‑lactamase–producing bacterial strains for effective treatment.

DMOXY-CLAV LB TAB
Amoxicillin 500 mg + Potassium Clavulanate 125 mg with lactic acid bacillus is a broad‑spectrum antibiotic with probiotics for respiratory, urinary, skin, and ENT infections. Clavulanate enhances Amoxicillin’s action against resistant bacteria, while lactic acid bacillus supports gut health and reduces antibiotic‑associated gastrointestinal disturbances.

dMOXY-CL CAP
Amoxicillin 250 mg + Cloxacillin 250 mg with lactic acid bacillus is a combination antibiotic with probiotics used for skin, respiratory, and soft tissue infections. Amoxicillin and Cloxacillin provide broad‑spectrum antibacterial action, while lactic acid bacillus maintains gut flora balance and minimizes gastrointestinal side effects.

Additional Information:

• Delivery Time: 5DAYS

DCEFI-200TAB

Cefixime 200 mg dispersible tablets are third-generation cephalosporin antibiotics used for treating respiratory, urinary, and gastrointestinal infections. They work by inhibiting bacterial cell wall synthesis, offering broad-spectrum activity against Gram-positive and Gram-negative bacteria, and are convenient for patients with swallowing difficulties.

Ciprofloxacin 500 mg + Tinidazole 600 mg is a combination antibiotic therapy for gastrointestinal, urinary, and gynecological infections. Ciprofloxacin inhibits bacterial DNA replication, while Tinidazole targets anaerobic bacteria and protozoa, providing broad‑spectrum coverage against mixed infections for effective and comprehensive treatment.